Oncolytics Biotech Inc. | Ownership
Companies that own Oncolytics Biotech Inc.
Millennium Management LLC
489,531
3.27%
489,531
0%
06/30/2018
Picton Mahoney Asset Management
54,895
0.37%
54,895
0.01%
06/30/2017
Morgan Stanley Canada Ltd.
42,757
0.28%
42,757
0.01%
06/30/2018
Comerica Bank (Investment Management)
15,526
0.1%
15,526
0%
06/30/2018
RBC Dominion Securities, Inc. (Investment Management)
8,899
0.06%
8,899
0%
06/30/2018
Morgan Stanley Smith Barney LLC (Private Banking)
4,225
0.03%
4,225
0%
06/30/2018
BMO Asset Management, Inc.
3,698
0.03%
3,698
0%
06/30/2018
UBS Securities LLC
3,609
0.02%
3,609
0%
06/30/2018
DWS Investment GmbH
2,717
0.02%
2,717
0%
06/30/2018
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)
1,677
0.01%
1,677
0%
06/30/2018
| Address |
1167 Kensington Crescent NW
Calgary Alberta T2N 1X7
Canada
|
|
Employees
|
- |
| Website |
http://www.oncolyticsbiotech.com |
| Updated |
07/08/2019 |
| Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus called REOLYSIN. The company was founded by Matthew C. |
